Autori: Karaferic Andjela
Naslov | Real-world experience with CDK4/6 inhibitors for metastatic HR+/HER2-breast cancer at a single cancer center (Meeting Abstract) |
Autori | Milovic-Kovacevic Marijana M ![]() ![]() |
Info | BREAST, (2023), vol. 68 br. , Suppl. S, str. S115-S115 |
Ispravka | Web of Science Elečas Rang časopisa |
|
Naslov | Real-World Experience with CDK4/6 Inhibitors for Metastatic HR +/HER2-Breast Cancer at a Single Cancer Center (Meeting Abstract) |
Autori | Milovic-Kovacevic Marijana M ![]() |
Info | BREAST, (2023), vol. 68 br. , Suppl. S, str. S46-S46 |
Ispravka | Web of Science Elečas Rang časopisa |
|
Naslov | TOLERABILITY OF BEVACIZUMAB IN METASTATIC TRIPLE-NEGATIVE BREAST CANCER (TNBC) PATIENTS: A SINGLE INSTITUTION EXPERIENCE (Meeting Abstract) |
Autori | Stamatovic Ljiljana Vasovic Suzana Milovic-Kovacevic Marijana M ![]() |
Info | BREAST, (2013), vol. 22 br. , Suppl. 3, str. S50-S51 |
Ispravka | Web of Science Elečas Rang časopisa Citati: Web of Science |
|
Naslov | Adjuvant Chemotherapy and Disease Outcome in Triple-Negative Breast Cancer: 3-Year Follow-Up Data (Meeting Abstract) |
Autori | Susnjar Snezana V ![]() ![]() |
Info | BREAST, (2013), vol. 22 br. , Suppl. 1, str. S93-S93 |
Ispravka | Web of Science Elečas Rang časopisa Citati: Web of Science |
|
Naslov | What is the Influence of Early Loco-regional Recurrence in Triple-negative Breast Cancer Patients on Disease Outcome? (Meeting Abstract) |
Autori | Posarac Vladan Susnjar Snezana V ![]() ![]() |
Info | EUROPEAN JOURNAL OF CANCER, (2012), vol. 48 br. , Suppl. 1, str. S139-S139 |
Ispravka | Web of Science Elečas Rang časopisa Citati: Web of Science |
|
Naslov | Triple-negative Breast Cancer - Which Classical Prognostic Factors Can Help in Identifying Patients with Early Relapse? (Meeting Abstract) |
Autori | Susnjar Snezana V ![]() ![]() ![]() |
Info | EUROPEAN JOURNAL OF CANCER, (2012), vol. 48 br. , Suppl. 1, str. S132-S132 |
Ispravka | Web of Science Elečas Rang časopisa Citati: Web of Science |
|
Naslov | The significance of HER-2 amplification and the size and type of pathological unicentric, initially operable clinical stage I and IIA/IIB breast cancer, in determining the treatment strategy (Article) |
Autori | Miletic Nebojsa M Golubicic Ivana Gavrilovic Dusica Dzodic Radan R ![]() |
Info | JOURNAL OF BUON, (2012), vol. 17 br. 1, str. 33-37 |
Ispravka | Web of Science Elečas Rang časopisa Citati: Web of Science Scopus |
|
Naslov | Do medullar histology and type of adjuvant chemotherapy influence the short term outcome of triple negative early breast cancer patients? (Meeting Abstract) |
Autori | Susnjar Snezana V ![]() ![]() ![]() |
Info | BREAST, (2011), vol. 20 br. , Suppl. Suppl. 1, str. S42-S42 |
Ispravka | Web of Science Elečas Rang časopisa Citati: Web of Science |
|
Naslov | Could the lack of expression of steroid receptors and HER2 discriminate a subgroup of triple negative breast cancer patients with poorer prognosis? (Meeting Abstract) |
Autori | Milovic-Kovacevic Marijana M ![]() ![]() ![]() |
Info | BREAST, (2011), vol. 20 br. , Suppl. Suppl. 1, str. S40-S41 |
Ispravka | Web of Science Elečas Rang časopisa Citati: Web of Science |
|
Naslov | EVALUATION OF PROGNOSTIC VALUE OF HER2 AND VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) EXPRESSION FOR PREDICTING EARLY FAILURE IN PATIENTS WITH OPERABLE BREAST CANCER (Meeting Abstract) |
Autori | Vasovic Suzana Stamatovic Ljiljana Tomasevic Zoran M Karaferic Andjela Pavlovic L Karadzic Katarina Jovanic Irena P |
Info | ANNALS OF ONCOLOGY, (2010), vol. 21 br. , Suppl. Suppl. 8, str. 90-90 |
Ispravka | Web of Science Elečas Rang časopisa Citati: Web of Science |
|